Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference9 articles.
1. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria;Maurer;N Engl J Med,2013
2. Omalizumab is effective in nonautoimmune urticaria;Ferrer;J Allergy Clin Immunol,2011
3. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria;Saini;J Allergy Clin Immunol,2011
4. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria;Zuberbier;Allergy,2014
5. European Public Assessment Report (EPAR) for Xolair 2014. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000606/WC500057298.pdf. Accessed April 4, 2015.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献